Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics

Learning Objectives:

• Describe the burden and impact on patient quality of life (QoL) of relapsed ovarian cancer
• Assess the mechanisms, clinical efficacy, safety data, and scientific rationale for treatment selection in a patient with relapsed ovarian cancer
• Appropriately counsel patients on adverse event management and reporting to minimize treatment stoppage
• Employ the shared decision-making process to develop a comprehensive treatment plan to addresses patient goals and treatment tolerability